A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy
Title:
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy
Author:
Zambelli, Alberto Cazzaniga, Marina La Verde, Nicla Munzone, Elisabetta Antonazzo, Ippazio Cosimo Mantovani, Lorenzo Giovanni Di Cosimo, Serena Mancuso, Anna Generali, Daniele Cortesi, Paolo Angelo